Short stature due to growth hormone qualitative anomaly is characterized by growth retardation and short stature (despite the presence of normal or slightly elevated levels of immunoreactive growth hormone, GH), low concentrations of insulin-like growth factor-I (IGF-I) and a significant increase in growth rate following recombinant GH therapy. Prevalence is unknown but only a few cases have been reported in the literature. The syndrome is caused by various mutations in the GH1 gene (17q22-q24) that result in structural GH anomalies and a biologically inactive molecule. Transmission is autosomal recessive.
Comprehensive, easy-to-understand information about this condition
Checking for content...
isolated growth hormone deficiency type II
MONDO:0008250
isolated growth hormone deficiency type IA
MONDO:0009876
isolated growth hormone deficiency type III
MONDO:0010615
isolated growth hormone deficiency type IB
MONDO:0013006
isolated growth hormone deficiency, type 4
MONDO:0032567
isolated growth hormone deficiency, type 5
MONDO:0032569